A Study of INCB059872 and INCB057643 in Relapsed or Refractory Ewing Sarcoma
Conditions: Relapsed Ewing Sarcoma; Refractory Ewing Sarcoma Interventions: Drug: INCB059872; Drug: INCB057643 Sponsor: Incyte Corporation Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - May 2, 2018 Category: Research Source Type: clinical trials